In this emergency podcast concerning the COVID-19 pandemic, Dr. David Parke II, CEO of the American Academy of Ophthalmology, joins the program to answer the most common questions facing ophthalmologists today: what are the recommendations for protecting patients, staff, and physicians from COVID-19 exposure? What are the implications for the future? Then, Dr. M. Ali Khan and Jay discuss when COVID-19 felt like reality in the United States. and the impact it has had on work and home life.
Read the Academy's guidelines, updated daily.
Financial Disclosures: None relevant for any participant of this episode. Dr. Sridhar is a consultant for Alcon, Alimera, and Oxurion. Dr. Parke is the current CEO of the American Academy of Ophthalmology.
CME Information
Release: March 16, 2020; expires March 16, 2023
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.